Dermatology · Baltimore, MD
NPI
1174941900
Since 2014
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
601 N Caroline St Ste 8065
Baltimore, MD, 21287
Phone (410) 955-5933
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
486 services
Medicare patients, 2024
175
Average age 67
Drug cost, 2024
$538K
182 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jun Kang was code 99214 (office e&m - established), 93 times for 73 patients. In total Jun Kang billed 486 services in 28 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 93 | 73 | $72.82 | $6,772 |
| 99215 Office E&M - Established | Facility | 51 | 24 | $109.00 | $5,559 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 42 | 22 | $13.07 | $549 |
| 11104 Skin Biopsy | Facility | 38 | 35 | $37.76 | $1,435 |
| 17003 Destruction Skin Lesion | Facility | 36 | 12 | $1.63 | $58.6 |
| 99222 Hospital E&M - Initial | Facility | 36 | 36 | $106.26 | $3,825 |
| 11105 Skin Biopsy | Facility | 33 | 22 | $20.98 | $692 |
| 11102 Skin Biopsy | Facility | 25 | 22 | $22.53 | $563 |
| 99204 Office E&M - New | Facility | 20 | 20 | $108.75 | $2,175 |
| 17000 Destruction Skin Lesion | Facility | 20 | 18 | $41.59 | $832 |
| 99213 Office E&M - Established | Facility | 17 | 16 | $47.44 | $807 |
By year: 2022 $48K for 819 services; 2023 $37K for 588 services; 2024 $28K for 486 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jun Kang prescribed most often to Medicare patients was Saphnelo (Anifrolumab-Fnia), with 35 prescriptions and refills. In total Jun Kang wrote 182 Medicare prescriptions that cost $538K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Saphnelo Anifrolumab-Fnia | 35 | 35 | Under 11 | $183K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 20 | 20 | Under 11 | $285K |
| Sodium Chloride 0.9 % Sodium Chloride | 17 | 17 | Under 11 | $197 |
| Diphenhydramine Hcl Generic | 16 | 16 | Under 11 | $44.96 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 12 | 12 | Under 11 | $16.8 |
Brand drugs: 90 claims; generic drugs: 92 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jun Kang $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.